[{"address1": "201 Haskins Way", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 695 0677", "website": "https://lyell.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops T cell reprogramming technologies for patients with solid tumors. The company develops therapies using an ex vivo genetic reprogramming technologies, such as c Jun overexpression and NR4A3 gene knockout, to endow resistance to T cell exhaustion; and an ex vivo epigenetic reprogramming technologies, including Epi R to generate population of T cells with durable stemness, and Stim R, a proprietary synthetic cell mimetic. It is also developing LYL797, a genetically and epigenetically reprogrammed ROR1 chimeric antigen receptor (CAR) T cell product candidate that is in Phase 1 clinical trial for the treatment of various solid tumors; and LYL845, a novel epigenetically reprogrammed tumor-infiltrating lymphocytes product candidate, which is in Phase 1 clinical trial targeting multiple solid tumor indications. In addition, the company's preclinical product candidates include LYL119, a ROR1 CAR T-cell product for the treatment of enhanced cytotoxicity; and second generation TIL product. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 224, "companyOfficers": [{"maxAge": 1, "name": "Dr. Richard D. Klausner M.D.", "age": 72, "title": "Founder & Executive Chairman", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 80000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lynn  Seely M.D., Ph.D.", "age": 65, "title": "President, CEO & Director", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 962226, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles W. Newton", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 744737, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen J. Hill", "age": 53, "title": "Chief Operating Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 775967, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary  Lee Ph.D.", "age": 46, "title": "Chief Scientific Officer", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 889676, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew  Lang J.D.", "age": 48, "title": "Chief Business Officer, Chief Legal Officer & Corporate Secretary", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 596253, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Stanley R. Riddell M.D.", "title": "Founder & Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Crystal L. Mackall M.D.", "age": 63, "title": "Founder & Scientific Advisor", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nellie  Dillery", "title": "Director of Accounting", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ellen  Rose", "title": "Senior Vice President of Communications & Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.582, "open": 0.605, "dayLow": 0.5884, "dayHigh": 0.6253, "regularMarketPreviousClose": 0.582, "regularMarketOpen": 0.605, "regularMarketDayLow": 0.5884, "regularMarketDayHigh": 0.6253, "beta": -0.36, "forwardPE": -1.3557777, "volume": 1759881, "regularMarketVolume": 1759881, "averageVolume": 1273501, "averageVolume10days": 1720710, "averageDailyVolume10Day": 1720710, "bid": 0.431, "ask": 0.7688, "bidSize": 200, "askSize": 200, "marketCap": 178248016, "fiftyTwoWeekLow": 0.509, "fiftyTwoWeekHigh": 3.256, "priceToSalesTrailing12Months": 2829.3335, "fiftyDayAverage": 0.66232, "twoHundredDayAverage": 1.39085, "currency": "USD", "enterpriseValue": -211619504, "floatShares": 206159748, "sharesOutstanding": 292161984, "sharesShort": 11525095, "sharesShortPriorMonth": 12314391, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0394, "heldPercentInsiders": 0.1372, "heldPercentInstitutions": 0.66609, "shortRatio": 14.5, "shortPercentOfFloat": 0.053200003, "impliedSharesOutstanding": 292161984, "bookValue": 2.068, "priceToBook": 0.29501933, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -203988992, "trailingEps": -0.79, "forwardEps": -0.84, "enterpriseToRevenue": -3359.04, "enterpriseToEbitda": 1.076, "52WeekChange": -0.72547174, "SandP52WeekChange": 0.22903383, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "LYEL", "underlyingSymbol": "LYEL", "shortName": "Lyell Immunopharma, Inc.", "longName": "Lyell Immunopharma, Inc.", "firstTradeDateEpochUtc": 1623936600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "c5ad7970-8aa2-3c85-a7aa-1e907d8cc7ab", "messageBoardId": "finmb_590661061", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.6101, "targetHighPrice": 1.0, "targetLowPrice": 0.6, "targetMeanPrice": 0.8, "targetMedianPrice": 0.8, "recommendationMean": 3.25, "recommendationKey": "hold", "numberOfAnalystOpinions": 2, "totalCash": 440547008, "totalCashPerShare": 1.578, "ebitda": -196600000, "totalDebt": 58575000, "quickRatio": 13.146, "currentRatio": 13.429, "totalRevenue": 63000, "debtToEquity": 11.037, "returnOnAssets": -0.19115, "returnOnEquity": -0.33216, "grossProfits": 63000, "freeCashflow": -83122752, "operatingCashflow": -155787008, "revenueGrowth": 0.36, "grossMargins": 1.0, "operatingMargins": -1485.4413, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]